1311254-56-4

Basic information

• Product Name: N-BOC-4-(HYDROXYMETHYL)ISOINDOLINE
• Synonyms: N-BOC-4-(HYDROXYMETHYL)ISOINDOLINE;4-Hydroxymethyl-1,3-dihydro-isoindole-2-carboxylic acid tert-butyl ester
• CAS NO: 1311254-56-4
• Molecular Formula: C14H19NO3
• Molecular Weight: 249.30556
• Mol File: 1311254-56-4.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N-BOC-4-(HYDROXYMETHYL)ISOINDOLINE(CAS DataBase Reference)
• NIST Chemistry Reference: N-BOC-4-(HYDROXYMETHYL)ISOINDOLINE(1311254-56-4)
• EPA Substance Registry System: N-BOC-4-(HYDROXYMETHYL)ISOINDOLINE(1311254-56-4)

Safety Data

• Hazardous Substances Data: 1311254-56-4(Hazardous Substances Data)

Upstream product

• 1035235-27-8 tert-butyl 4-bromo-2,3-dihydro-1H-isoindole-2-carboxylate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 775545-06-7 methyl isoindoline-4-carboxylate 
• 1049677-40-8 tert-butyl 4-formyl-1,3-dihydro-2H-isoindole-2-carboxylate 

Downstream Products

• 1049677-40-8 tert-butyl 4-formyl-1,3-dihydro-2H-isoindole-2-carboxylate 

Relevant articles and documents

INHIBITORS OF MLH1 AND/OR PMS2 FOR CANCER TREATMENT

The present invention relates to compounds of Formula (I) that target the MLH1 and/or PMS2 proteins that are components of the DNA Mismatch Repair (MMR) process: Formula (I) wherein R1, R2, R3, R4, R6

QUINOXALINE COMPOUND

[Problem] Provided is a compound which has a PDE9-inhibitory action and is useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, and bladder/urethral diseases, and the like. [Means for Solutio